All > Adenocarcinoma

18F-Clofarabine for Metastatic Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Metastatic Cancer+2 More18F-Clofarabine - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether a new imaging agent, 18F-Clofarabine, can be used to show pyrimidine metabolism in order to better predict whether cancer drugs will be effective.

Eligible Conditions
  • Metastatic Cancer
  • Adenocarcinoma
  • Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
[18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine)
1
18F-flutemetamol
1
4-[18F]Fluoro-1-Naphthol

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: up to 60 minutes after CFA PET

Month 12
Correlate CFA uptake with OS
Correlate CFA uptake with PFS
Month 3
Correlate CFA uptake with conventional imaging
up to 60 minutes after CFA PET
Evaluate CFA as a PET imaging agent
within 48 hrs of radiotracer administration
Adverse Events

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
[18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine)
1
18F-flutemetamol
1
4-[18F]Fluoro-1-Naphthol

Trial Design

1 Treatment Group

18F-Clofarabine
1 of 1

Experimental Treatment

15 Total Participants · 1 Treatment Group

Primary Treatment: 18F-Clofarabine · No Placebo Group · Phase < 1

18F-Clofarabine
Drug
Experimental Group · 1 Intervention: 18F-Clofarabine · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 60 minutes after cfa pet

Who is running the clinical trial?

Omar MianLead Sponsor
Omar Mian, MDPrincipal InvestigatorCleveland Clinic, Case Comprehensive Cancer Center

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a histologically or cytologically proven carcinoma or adenocarcinoma.
You are at least 18 years old.
Total serum bilirubin < 2.0 x ULN.
You have a platelet count of at least 75,000/uL.
Hemoglobin > or = 8.0 g/dL.

Who else is applying?

What state do they live in?
California100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top